Immucyst



Indications and Reactions:

Role Indications Reactions
Primary
Bladder Cancer 65.4%
Carcinoma In Situ Of Bladder 8.9%
Product Used For Unknown Indication 6.8%
Transitional Cell Carcinoma 2.6%
Bladder Cancer Recurrent 2.6%
Drug Use For Unknown Indication 2.3%
Bladder Transitional Cell Carcinoma 2.0%
Hypertension 1.8%
Immunisation 0.9%
Type 2 Diabetes Mellitus 0.9%
Bladder Cancer Stage 0, With Cancer In Situ 0.8%
Urinary Tract Carcinoma In Situ 0.8%
Carcinoma In Situ 0.7%
Malignant Neoplasm Of Renal Pelvis 0.7%
Ureteric Cancer 0.6%
Prophylaxis 0.5%
Atrial Fibrillation 0.5%
Hypercholesterolaemia 0.5%
Benign Prostatic Hyperplasia 0.4%
Depression 0.4%
Pyrexia 30.5%
Reiter's Syndrome 10.1%
Pollakiuria 9.0%
Bovine Tuberculosis 5.6%
Tuberculosis 5.5%
Urinary Tract Infection 4.2%
Vomiting 3.5%
Haematuria 3.3%
White Blood Cell Count Increased 3.0%
Cystitis 2.7%
Orchitis 2.5%
Sepsis 2.5%
Contracted Bladder 2.4%
Pyuria 2.4%
Urinary Retention 2.4%
Prostatitis 2.3%
Septic Shock 2.1%
Disseminated Tuberculosis 2.0%
Interstitial Lung Disease 2.0%
Renal Impairment 2.0%
Secondary
Bladder Cancer 56.2%
Carcinoma In Situ Of Bladder 10.1%
Transitional Cell Carcinoma 3.6%
Product Used For Unknown Indication 3.5%
Bladder Cancer Recurrent 3.2%
Antibiotic Prophylaxis 2.3%
Bladder Transitional Cell Carcinoma 1.9%
Epididymitis 1.9%
Hypertension 1.9%
Convulsion 1.8%
Infection Prophylaxis 1.8%
Depression 1.5%
Hypercholesterolaemia 1.5%
Type 2 Diabetes Mellitus 1.5%
Malignant Neoplasm Of Renal Pelvis 1.4%
Ureteric Cancer 1.4%
Drug Use For Unknown Indication 1.3%
Urinary Tract Carcinoma In Situ 1.3%
Atrial Fibrillation 1.0%
Urinary Bladder Polyp 0.8%
Pyrexia 27.5%
Urinary Tract Infection 9.0%
Pollakiuria 7.3%
Pyuria 6.1%
White Blood Cells Urine Positive 5.8%
Vomiting 5.1%
White Blood Cell Count Increased 4.6%
Oxygen Saturation Decreased 3.4%
Septic Shock 3.4%
Urine Abnormality 3.2%
Restlessness 2.9%
Cystitis 2.7%
Epididymitis 2.7%
Prostatitis 2.7%
Scrotal Pain 2.7%
Pain 2.2%
Renal Impairment 2.2%
Sepsis 2.2%
Ureteritis 2.2%
Urinary Bladder Haemorrhage 2.2%